Valentin Razvan Curt

Valentin Razvan Curt has an extensive work experience in the pharmaceutical industry. Valentin Razvan started their career as a Medical Monitor at ClinTrials Research Inc. in 1996 and later became a Medical Director at Aronex Pharmaceuticals in 1999. In 2001, they served as the Director of Clinical Drug Development at Tanox, Inc. and then joined Boehringer Ingelheim Pharmaceuticals as a Consultant Clinical Research Physician in 2003. Valentin Razvan Curt continued to progress in their career and held the role of Director, Principal Medical Scientific Expert at Novartis from 2006 to 2011. Valentin Razvan then became the Senior Director, Clinical Development at Daiichi Sankyo from 2011 to 2016. Valentin Razvan Curt joined Purdue Pharma L.P. as an Executive Medical Director in 2016 and worked there until 2020. Valentin Razvan then joined Imbrium Therapeutics as the Executive Medical Director, Clinical R&D from 2019 to 2020. Currently, Valentin Razvan Curt is working at Eagle Pharmaceuticals, Inc. as the Senior Vice President, Clinical Drug Development since September 2020 and also holds the position of Interim Chief Medical Officer since January 2022.

Valentin Razvan Curt attended Universitatea de Medicină și Farmacie din Craiova from 1985 to 1991, where they obtained their M.D. degree in General Medicine.